Showing results for bntx investor relations
Search instead for bntcw investor relations
The Investor Relations website contains information about BioNTech's business for stockholders, potential investors, and financial analysts.
Investor FAQs. Annual General Meeting. Annual ... Corporate Presentation. September 13, 2023 ... BNTX: clinical data update BNT162. July 1, 2020 at 5:00 PM CEST.
The Investor Relations website contains information about BioNTech's business for stockholders, potential investors, and financial analysts.
Missing: relations | Show results with:relations
D. VP Investor Relations & Business Strategy. Tel: +49 (0)6131 9084 1074. E-mail: Investors@biontech.de.
Why Invest · Our Story · Prospective Investors · Sustainability Bond · Financials · Quarterly Results · Annual Reports · SEC Filings · Stock Info · Stock Quote ...
People also ask
Who are the major shareholders of Biontech?
Get the latest insights on BioNTech SE American Depositary Share (BNTX) ... BioNTech SE American Depositary Share (BNTX) ... Investor Relations · Contact · Careers ...
Mar 6, 2024 · Investor Relations Victoria Meissner, M.D. +1 617 528 8293. Investors@biontech.de. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513
In this annual report on Form 20-F (“Annual Report”), “BioNTech,” the “Group,” the “Company,” “we,” “us,” and “our” refer to BioNTech SE and its consolidated ...
Mar 6, 2024 · Investor Relations Victoria Meissner, M.D. +1 617 528 8293. Investors@biontech.de. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513
Oct 23, 2023 · Investor Relations Victoria Meissner, M.D. +1 617 528 8293. Investors@biontech.de. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513